Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

Clear filters
ClinicalTrials.gov public records Last synced Jul 25, 2026, 9:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 24 matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
Filters: Sponsor: Georgetown University Clear all
Completed Phase 2 Interventional

Mifepristone (RU-486) in Androgen Independent Prostate Cancer

NCT00140478
View directory record Official record
Conditions
Prostate Cancer, Adenocarcinoma of Prostate
Interventions
Mifepristone
Drug
Lead sponsor
Dana-Farber Cancer Institute
Other
Eligibility
18 Years and older · Male only
Enrollment
48 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2005 – 2008
U.S. locations
4
States / cities
Washington D.C., District of Columbia • Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Dec 8, 2009 · Synced Jul 25, 2026, 9:14 AM EDT
Terminated Phase 2 Interventional Results available

Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and PEG-Intron

NCT02982720
View directory record Official record
Conditions
Advanced Cholangiocarcinoma
Interventions
Pembrolizumab, Sylatron
Drug
Lead sponsor
Aiwu Ruth He, MD
Other
Eligibility
18 Years and older
Enrollment
4 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2017 – 2018
U.S. locations
1
States / cities
Washington D.C., District of Columbia
Source: ClinicalTrials.gov public record
Updated Feb 15, 2022 · Synced Jul 25, 2026, 9:14 AM EDT
Completed Not applicable Interventional

An Exercise Intervention for Prostate Cancer Patients Receiving Androgen Deprivation Therapy

NCT02248350
View directory record Official record
Conditions
Prostate Cancer, Physical Activity, Side-effects
Interventions
Supervised and Home Based Exercise, Stretching Control Group
Behavioral
Lead sponsor
Georgetown University
Other
Eligibility
40 Years to 70 Years · Male only
Enrollment
19 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2014 – 2017
U.S. locations
1
States / cities
Washington D.C., District of Columbia
Source: ClinicalTrials.gov public record
Updated Feb 14, 2018 · Synced Jul 25, 2026, 9:14 AM EDT
Completed Not applicable Interventional

Markers of Recovery in StrokE Study (MORSE)

NCT03666897
View directory record Official record
Conditions
Stroke
Interventions
DTI Images and Plasma Biomarkers
Other
Lead sponsor
Corewell Health West
Other
Eligibility
18 Years and older
Enrollment
21 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2018 – 2022
U.S. locations
1
States / cities
Grand Rapids, Michigan
Source: ClinicalTrials.gov public record
Updated Feb 27, 2024 · Synced Jul 25, 2026, 9:14 AM EDT
Completed Phase 4 Interventional Results available

Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients

NCT00998426
View directory record Official record
Conditions
Hepatitis B
Interventions
glucose monitoring before and after HepaGam B administration, HepaGam B (Hepatitis B Immune Globulin (HBIG))
Procedure · Biological
Lead sponsor
Georgetown University
Other
Eligibility
18 Years and older
Enrollment
5 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2009 – 2011
U.S. locations
1
States / cities
Washington D.C., District of Columbia
Source: ClinicalTrials.gov public record
Updated Sep 27, 2015 · Synced Jul 25, 2026, 9:14 AM EDT
Withdrawn Phase 4 Interventional Accepts healthy volunteers

Study Evaluating AWBAT-D Versus the Standard of Care of Split-thickness Skin Graft Donor Sites

NCT01252836
View directory record Official record
Conditions
Healing of Donor Site, Pain Level
Interventions
AWBAT-D
Device
Lead sponsor
Georgetown University
Other
Eligibility
18 Years and older
Healthy volunteers
Accepts healthy volunteers
Timeline
2010 – 2015
U.S. locations
1
States / cities
Washington D.C., District of Columbia
Source: ClinicalTrials.gov public record
Updated Dec 14, 2016 · Synced Jul 25, 2026, 9:14 AM EDT
Recruiting Not applicable Interventional

Improving Genetic Counseling for BRCA+ Mothers

NCT04258280
View directory record Official record
Conditions
Breast Cancer
Interventions
Education and counseling, Education
Behavioral
Lead sponsor
Georgetown University
Other
Eligibility
18 Years and older · Female only
Enrollment
200 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2020 – 2025
U.S. locations
1
States / cities
Washington D.C., District of Columbia
Source: ClinicalTrials.gov public record
Updated Sep 26, 2024 · Synced Jul 25, 2026, 9:14 AM EDT
Completed Phase 3 Interventional Accepts healthy volunteers

Lombardi Comprehensive Cancer Center/Legacy Pilot Study to Reduce Adverse Smoking Outcomes in the Context of Lung Cancer Screening

NCT02267096
View directory record Official record
Conditions
Smoking, Lung Cancer
Interventions
Telephone Counseling, Minimal Treatment
Behavioral
Lead sponsor
Georgetown University
Other
Eligibility
55 Years to 80 Years
Enrollment
95 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2014 – 2016
U.S. locations
3
States / cities
Washington D.C., District of Columbia • Burlington, Massachusetts • Hackensack, New Jersey
Source: ClinicalTrials.gov public record
Updated Oct 18, 2016 · Synced Jul 25, 2026, 9:14 AM EDT
Completed No phase listed Observational

Patient Self Monitoring to Evaluate 30 Day Post Discharge Heart Failure Outcomes

NCT02527759
View directory record Official record
Conditions
Heart Failure
Interventions
Survey
Behavioral
Lead sponsor
Georgetown University
Other
Eligibility
65 Years and older
Enrollment
56 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2016 – 2017
U.S. locations
2
States / cities
Washington D.C., District of Columbia
Source: ClinicalTrials.gov public record
Updated Oct 19, 2017 · Synced Jul 25, 2026, 9:14 AM EDT
Terminated Phase 1 Interventional

Vascular Sealant Study

NCT00618358
View directory record Official record
Conditions
Arteriovenous Access Grafts or Extra-anatomic and Infra-inguinal Grafts
Interventions
Vascular Sealant System, Gelfoam/Thrombin
Device · Other
Lead sponsor
Georgetown University
Other
Eligibility
18 Years and older
Timeline
Started 2007
U.S. locations
1
States / cities
Washington D.C., District of Columbia
Source: ClinicalTrials.gov public record
Updated Mar 26, 2015 · Synced Jul 25, 2026, 9:14 AM EDT
Completed Phase 1 Interventional

Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced Malignancies

NCT00024648
View directory record Official record
Conditions
Neoplasms
Interventions
LErafAON
Drug
Lead sponsor
INSYS Therapeutics Inc
Industry
Eligibility
18 Years and older
Enrollment
25 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2001 – 2004
U.S. locations
4
States / cities
Washington D.C., District of Columbia • Chicago, Illinois • Philadelphia, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Apr 12, 2011 · Synced Jul 25, 2026, 9:14 AM EDT
Suspended Phase 2 Interventional

Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial

NCT05928806
View directory record Official record
Conditions
Advanced Renal Cell Carcinoma
Interventions
Botensilimab, Balstilimab, Ipilimumab, Nivolumab
Drug
Lead sponsor
Michael B. Atkins, MD
Other
Eligibility
18 Years and older
Enrollment
120 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2027
U.S. locations
13
States / cities
La Jolla, California • New Haven, Connecticut • Washington D.C., District of Columbia + 9 more
Source: ClinicalTrials.gov public record
Updated Feb 10, 2026 · Synced Jul 25, 2026, 9:14 AM EDT
Completed Not applicable Interventional

Stroke Transitions of Care to Reduce Hospital Length of Stay

NCT04434638
View directory record Official record
Conditions
Stroke
Interventions
Transitions of Care Coordinator, Usual Care
Other
Lead sponsor
Georgetown University
Other
Eligibility
18 Years and older
Enrollment
40 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2018 – 2019
U.S. locations
1
States / cities
Washington D.C., District of Columbia
Source: ClinicalTrials.gov public record
Updated Jun 16, 2020 · Synced Jul 25, 2026, 9:14 AM EDT
Completed No phase listed Observational

Eliminating the Need for Pancreas Biopsy Using Peripheral Blood Cell-free DNA

NCT04166149
View directory record Official record
Conditions
Transplant;Failure,Kidney, Transplant; Failure, Pancreas, Rejection Acute Renal, Rejection Acute Pancreas
Interventions
dd-cfDNA Blood Test
Diagnostic Test
Lead sponsor
University of Maryland, Baltimore
Other
Eligibility
18 Years and older
Enrollment
140 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2024
U.S. locations
3
States / cities
Washington D.C., District of Columbia • Baltimore, Maryland • Madison, Wisconsin
Source: ClinicalTrials.gov public record
Updated Nov 26, 2024 · Synced Jul 25, 2026, 9:14 AM EDT
Terminated Not applicable Interventional Results available

Endoscopic Evaluation of Late Rectal Injury Following CyberKnife Radiosurgery for Prostate Cancer

NCT01618838
View directory record Official record
Conditions
Stage II Prostate Carcinoma
Interventions
CyberKnife radiosurgery
Radiation
Lead sponsor
Georgetown University
Other
Eligibility
18 Years and older · Male only
Enrollment
4 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2011 – 2012
U.S. locations
1
States / cities
Washington, Virginia
Source: ClinicalTrials.gov public record
Updated Aug 21, 2018 · Synced Jul 25, 2026, 9:14 AM EDT
Completed Phase 1 Interventional

A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer

NCT01050985
View directory record Official record
Conditions
Advanced Solid Tumors
Interventions
Temsirolimus and capecitabine
Drug
Lead sponsor
Georgetown University
Other
Eligibility
18 Years and older
Enrollment
47 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2010 – 2013
U.S. locations
1
States / cities
Washington D.C., District of Columbia
Source: ClinicalTrials.gov public record
Updated Feb 12, 2014 · Synced Jul 25, 2026, 9:14 AM EDT
Active, not recruiting Phase 2 Interventional

Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer

NCT06015724
View directory record Official record
Conditions
Pancreatic Ductal Adenocarcinoma, Refractory Non-Small Cell Lung Cancer
Interventions
Daratumumab, KRAS vaccine, Nivolumab
Drug · Biological
Lead sponsor
Georgetown University
Other
Eligibility
18 Years and older
Enrollment
19 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2027
U.S. locations
1
States / cities
Washington D.C., District of Columbia
Source: ClinicalTrials.gov public record
Updated Jun 29, 2026 · Synced Jul 25, 2026, 9:14 AM EDT
Terminated Phase 2Phase 3 Interventional Results available

A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys

NCT01878786
View directory record Official record
Conditions
Delayed Graft Function
Interventions
Everolimus, Tacrolimus, Mycophenolate mofetil (MMF/MPA)
Drug
Lead sponsor
Matthew Cooper
Other
Eligibility
18 Years to 65 Years
Enrollment
25 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013 – 2017
U.S. locations
1
States / cities
Washington D.C., District of Columbia
Source: ClinicalTrials.gov public record
Updated Apr 25, 2019 · Synced Jul 25, 2026, 9:14 AM EDT
Completed No phase listed Observational Accepts healthy volunteers

Urban Environmental Exposures and Childhood Cancer

NCT00505141
View directory record Official record
Conditions
Brain Cancer, Acute Lymphoblastic Leukemia
Interventions
Not listed
Lead sponsor
Georgetown University
Other
Eligibility
Up to 18 Years
Healthy volunteers
Accepts healthy volunteers
Timeline
2004 – 2006
U.S. locations
1
States / cities
Washington D.C., District of Columbia
Source: ClinicalTrials.gov public record
Updated Jul 22, 2007 · Synced Jul 25, 2026, 9:14 AM EDT
Completed No phase listed Observational

ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

NCT04467931
View directory record Official record
Conditions
Hypertension, COVID
Interventions
ACEI/ARB, Non-ACEI/ARB, ACEI, ARB
Drug
Lead sponsor
University of Utah
Other
Eligibility
18 Years and older
Enrollment
22,213 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2020
U.S. locations
1
States / cities
Salt Lake City, Utah
Source: ClinicalTrials.gov public record
Updated Apr 27, 2021 · Synced Jul 25, 2026, 9:14 AM EDT
Completed Not applicable Interventional Results available

Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia

NCT01709383
View directory record Official record
Conditions
Aphasia
Interventions
Transcranial Direct Current Stimulation, Sham Stimulation
Device
Lead sponsor
Georgetown University
Other
Eligibility
18 Years and older
Enrollment
38 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2012 – 2015
U.S. locations
2
States / cities
Washington D.C., District of Columbia
Source: ClinicalTrials.gov public record
Updated Jul 5, 2017 · Synced Jul 25, 2026, 9:14 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Exercise Intervention Metabolic Syndrome Prostate Cancer Black Men

NCT02379559
View directory record Official record
Conditions
Physical Activity, Metabolic Syndrome, Prostate Cancer
Interventions
Exercise, Attention Control
Behavioral
Lead sponsor
Georgetown University
Other
Eligibility
40 Years to 40 Years · Male only
Enrollment
10 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2013 – 2017
U.S. locations
1
States / cities
Washington D.C., District of Columbia
Source: ClinicalTrials.gov public record
Updated Feb 22, 2017 · Synced Jul 25, 2026, 9:14 AM EDT
Completed No phase listed Observational Accepts healthy volunteers

Measurement of Hormone Levels in Patients Receiving 17-HPC for Preterm Delivery

NCT00457886
View directory record Official record
Conditions
Preterm Delivery
Interventions
Not listed
Lead sponsor
Georgetown University
Other
Eligibility
18 Years to 45 Years · Female only
Enrollment
20 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2005 – 2007
U.S. locations
1
States / cities
Washington D.C., District of Columbia
Source: ClinicalTrials.gov public record
Updated Mar 8, 2017 · Synced Jul 25, 2026, 9:14 AM EDT
Completed Not applicable Interventional

Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis

NCT00004495
View directory record Official record
Conditions
End Stage Renal Disease, Hyperhomocysteinemia
Interventions
cyanocobalamin, folic acid, pyridoxine
Drug
Lead sponsor
Georgetown University
Other
Eligibility
21 Years to 89 Years
Enrollment
84 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
1999 – 2000
U.S. locations
1
States / cities
Washington D.C., District of Columbia
Source: ClinicalTrials.gov public record
Updated Mar 24, 2015 · Synced Jul 25, 2026, 9:14 AM EDT